A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

NCT00742261 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumours

Interventions

DRUG: GSK1363089

Sponsor

GlaxoSmithKline